Corbus Pharmaceuticals Holdings Inc (CRBP)
38.77
+0.57
(+1.49%)
USD |
NASDAQ |
May 03, 16:00
38.81
+0.04
(+0.10%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings Research and Development Expense (Quarterly): 6.980M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.980M |
| September 30, 2023 | 6.550M |
| June 30, 2023 | 4.249M |
| March 31, 2023 | 13.39M |
| December 31, 2022 | 6.243M |
| September 30, 2022 | 4.108M |
| June 30, 2022 | 2.500M |
| March 31, 2022 | 3.286M |
| December 31, 2021 | 5.764M |
| September 30, 2021 | 8.696M |
| June 30, 2021 | 11.27M |
| March 31, 2021 | 10.72M |
| December 31, 2020 | 16.11M |
| September 30, 2020 | 27.52M |
| June 30, 2020 | 30.69M |
| March 31, 2020 | 23.95M |
| December 31, 2019 | 23.49M |
| September 30, 2019 | 22.15M |
| June 30, 2019 | 22.18M |
| March 31, 2019 | 21.78M |
| December 31, 2018 | 15.78M |
| Date | Value |
|---|---|
| September 30, 2018 | 12.81M |
| June 30, 2018 | 10.26M |
| March 31, 2018 | 9.765M |
| December 31, 2017 | 8.287M |
| September 30, 2017 | 5.622M |
| June 30, 2017 | 5.764M |
| March 31, 2017 | 6.366M |
| December 31, 2016 | 5.380M |
| September 30, 2016 | 4.316M |
| June 30, 2016 | 3.567M |
| March 31, 2016 | 2.174M |
| December 31, 2015 | 1.823M |
| September 30, 2015 | 1.635M |
| June 30, 2015 | 1.707M |
| March 31, 2015 | 0.7234M |
| December 31, 2014 | 0.5716M |
| September 30, 2014 | 0.4526M |
| June 30, 2014 | 0.1694M |
| March 31, 2014 | 0.0619M |
| December 31, 2013 | -0.0153M |
| September 30, 2013 | 0.029M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
2.500M
Minimum
Jun 2022
30.69M
Maximum
Jun 2020
13.15M
Average
10.72M
Median
Mar 2021
Research and Development Expense (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 3.20M |
| Perspective Therapeutics Inc | 6.08M |
| Protalix BioTherapeutics Inc | 3.102M |
| Electromed Inc | 0.107M |
| Armata Pharmaceuticals Inc | 7.928M |